DE

Preclinical study

Preclinical studies are a crucial phase in the development of new drugs and medical treatments, to ensure that new treatments are both safe and effective before tested in humans. These studies are designed to gather important data on the feasibility, safety, and biological activity of a new treatment. Typically, preclinical studies involve both in vitro (test tube or cell culture) and in vivo (animal) experiments.

The primary goals of preclinical studies are to:

  1. Assess Safety: Determine the potential toxicity of a new treatment and identify any adverse effects. This includes studying the effects on various organs and systems within the body.
  2. Evaluate Efficacy: Investigate whether the treatment has the desired therapeutic effect in a controlled environment.
  3. Understand Pharmacokinetics: Study how the drug is absorbed, distributed, metabolized, and excreted in the body. This helps in understanding the drug’s behavior and optimizing dosage.
  4. Understand Pharmacodynamics: Examine the biochemical and physiological effects of the drug and its mechanisms of action.
  5. Determine Starting Dose for Humans: Use the data collected to estimate a safe starting dose for the first-in-human clinical studies.

Preclinical studies are essential for several reasons:

  1. Risk Mitigation: By identifying potential safety issues early, preclinical studies help prevent harmful effects in human participants during clinical studies.
  2. Regulatory Approval: Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), require comprehensive preclinical data before approving a new treatment for clinical studies. This ensures that only treatments with a reasonable safety profile proceed to human testing.
  3. Scientific Foundation: These studies provide a scientific basis for the clinical development of new treatments, helping researchers understand the underlying mechanisms and potential benefits.

Cost-Effectiveness: Conducting preclinical studies can save time and resources by identifying ineffective or unsafe treatments early in the development process, reducing the likelihood of costly failures in later stages.